A Novel Chemically Modified Curcumin Reduces Severity of Experimental Periodontal Disease in Rats: Initial Observations

Tetracycline-based matrix metalloproteinase- (MMP-) inhibitors are currently approved for two inflammatory diseases, periodontitis and rosacea. The current study addresses the therapeutic potential of a novel pleiotropic MMP-inhibitor not based on an antibiotic. To induce experimental periodontitis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Elburki, Muna S., Rossa, Carlos, Guimaraes, Morgana R., Goodenough, Mark, Lee, Hsi-Ming, Curylofo, Fabiana A., Zhang, Yu, Johnson, Francis, Golub, Lorne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101223/
https://www.ncbi.nlm.nih.gov/pubmed/25104884
http://dx.doi.org/10.1155/2014/959471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101223/
https://www.ncbi.nlm.nih.gov/pubmed/25104884
http://dx.doi.org/10.1155/2014/959471

Ejemplares similares